Proteins and Peptides

12 Feb 2008 Phase III program for AVE0010/ZP10 licensed from Zealand Pharma A/S will begin in the first quarter of 2008
12 Feb 2008 Compugen Announces In-Vivo Results for Two Novel Peptide Agonists of MAS GPCR for Potential Treatment of Cardiovascular Pathologies
12 Feb 2008 Valeant Pharmaceuticals reports positive Phase III results for retigabine in RESTORE 1
12 Feb 2008 Bentley Pharmaceuticals Announces Completion of Treatment in Phase II India Clinical Study in Type 2 Diabetes and Preliminary Clinical Results
11 Feb 2008 Unigene Initiates Phase I/II Clinical Study for Oral Calcitonin
11 Feb 2008 SciClone and Sigma-Tau Report Promising Interim Results From Phase 3 Hepatitis C Trial
07 Feb 2008 Nile Therapeutics Announces Dosing of First Heart Failure Patient in Phase Ib Study of CD-NP
07 Feb 2008 Tornier And BioSET Enter Synthetic Growth Factor Pact
06 Feb 2008 Neose Receives Milestone Payment from Novo Nordisk on Factor VIII Program
05 Feb 2008 Althea Technologies Chosen by Quintessence Biosciences to Produce Lead Protein Oncology Drug
04 Feb 2008 AIM Therapeutics Advances Asthma Therapeutics Program
04 Feb 2008 IDM Pharma Announces Phase 3 Mifamurtide (L-MTP-PE) Study Demonstrating Improved Survival Published in the Journal of Clinical Oncology
04 Feb 2008 ATryn(R) Meets Primary Endpoint
31 Jan 2008 FDA Accepts for Filing a Biologic License Application (BLA) for Dysport(R) in Cervical Dystonia
31 Jan 2008 FDA Grants Priority Review for Schering-Plough's Peginterferon Alfa-2b for the Adjuvant Treatment of Patients With Stage III Melanoma
30 Jan 2008 Lev Pharmaceuticals Receives Complete Response Letter for Cinryze(TM)
29 Jan 2008 Compugen Announces In-Vivo Results for Two Peptide Anti-Inflammatory and Cardio-Protective Drug Candidates
29 Jan 2008 Neose Announces Discontinuation of NE-180 Program
29 Jan 2008 Mentor Announces Completion of Subject Enrollment into Phase IIIb Pivotal Trial for Botulinum Toxin Type A
28 Jan 2008 Orthologic Announces FDA Acceptance of AZX100 IND Application in Dermal/Hypertrophic Scarring; Phase 1 Human Clinical Trial to Begin 1Q2008
28 Jan 2008 NPS Pharmaceuticals Provides Update on GATTEX(TM) Clinical Development in Short Bowel Syndrome
25 Jan 2008 Preclinical studies on pulmonary arterial hypertension – Proteo cooperates with Stanford University, USA
24 Jan 2008 Cangene's recombinant human growth hormone approved by the U.S. Food and Drug Administration
24 Jan 2008 Nuvelo Announces Results from Phase 3 NAPA Program in Acute Peripheral Arterial Occlusion
24 Jan 2008 Takeda Doses First Patient in A U.S. Phase 1 Study of Hematide(TM) to Treat Chemotherapy Induced Anemia

La Merie Biologics

FREE Weekly News Bulletin

Sign Up

2022 Sales ofAntibodies & Proteins

New Product Alert

For La Merie Publishing

Sign Up